BOLT vs DD · rev $7.7M vs P/E 127, rev $12.39B
Bolt Biotherapeutics (BOLT) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
BOLT currently screens at market cap $11.3M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the BOLT and DD stock pages for the full models.
Not investment advice.